F.D.A. Approves Onglyza, a New Drug for Type 2 Diabetes
Federal regulators on Friday approved a potential blockbuster diabetes drug from Bristol-Myers Squibb and AstraZeneca.
The Food and Drug Administration said it approved the drug Onglyza to reduce blood sugar levels in patients with type 2 diabetes, which affects 24 million people in the United States.
Publication Date:
01/08/2009